Physician
Blanche, Mercedes
Blanche, Mercedes was paid $1.58M by Medicaid between Jan 2018 and Nov 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoBLANCHE, MERCEDES
NEWBURGH, NY 12550
NEWBURGH, NY 12550
33aNPI1396905055assigned 06/16/2008
33bProvider typePediatrics Physician
28Total paid$1.58M
24GClaims66,234
24DCodes billed61
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#208 of 1,983
Median peer was paid$17K
This provider vs. median93×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,988 | $241K | |
| 2019 | 10,882 | $303K | |
| 2020 | 11,063 | $263K | |
| 2021 | 11,692 | $287K | |
| 2022 | 9,449 | $206K | |
| 2023 | 7,320 | $139K | |
| 2024incomplete | 6,840 | $138K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 10,115 | 8,366 | $581K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.4% | 7,017 | 6,502 | $133K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.4% | 4,585 | 4,352 | $132K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 1,684 | 1,681 | $116K |
| 92587 | 7.0% | 5,220 | 5,192 | $110K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.3% | 1,399 | 1,399 | $99K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.0% | 1,474 | 1,350 | $94K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.1% | 825 | 824 | $64K |
| 99401 | 2.5% | 6,345 | 6,110 | $40K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 1,145 | 1,129 | $37K |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 1.6% | 3,164 | 3,162 | $26K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.4% | 283 | 262 | $23K |
49 more codes
| 90461 | 1.4% | 1,388 | $22K | |
| 99173 | <1% | 3,430 | $15K | |
| 99188 | <1% | 882 | $15K | |
| 4124F | <1% | 600 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,017 | $7K |
| 83655 | <1% | 1,213 | $6K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 961 | $5K |
| 36406 | <1% | 401 | $5K | |
| 99354 | <1% | 83 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 41 | $4K |
| D1206 | Topical application of fluoride varnish | <1% | 127 | $4K |
| 86804 | <1% | 281 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 259 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 182 | $3K |
| 86756 | <1% | 409 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 639 | $2K |
| 99422 | <1% | 97 | $2K | |
| 94664 | <1% | 168 | $1K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 62 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 376 | $1K |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 258 | $545.15 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 900 | $428.28 |
| 99421 | <1% | 19 | $214.31 | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 64 | $165.49 |
| 81003 | <1% | 64 | $108.00 | |
| 94760 | <1% | 142 | $53.64 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 51 | $46.07 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 223 | $38.72 |
| 90686 | 0% | 2,737 | $0.00 | |
| 90651 | 0% | 97 | $0.00 | |
| 90680 | 0% | 222 | $0.00 | |
| 90620 | 0% | 24 | $0.00 | |
| 90677 | 0% | 113 | $0.00 | |
| 90660 | 0% | 52 | $0.00 | |
| 90656 | 0% | 179 | $0.00 | |
| 90698 | 0% | 140 | $0.00 | |
| 90744 | 0% | 42 | $0.00 | |
| 90672 | 0% | 120 | $0.00 | |
| 90633 | 0% | 252 | $0.00 | |
| 90670 | 0% | 573 | $0.00 | |
| 99072 | 0% | 208 | $0.00 | |
| 90710 | 0% | 38 | $0.00 | |
| 90671 | 0% | 101 | $0.00 | |
| 99080 | 0% | 542 | $0.00 | |
| 90685 | 0% | 99 | $0.00 | |
| 90681 | 0% | 13 | $0.00 | |
| 90707 | 0% | 37 | $0.00 | |
| 90734 | 0% | 26 | $0.00 | |
| 90648 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.